April 13 (Reuters) - Medicover AB MCOVb.ST :
* TRADING UPDATE Q1 - COVID-19 THIRD WAVE DRIVES PERFORMANCE
* CONSOLIDATED REVENUE FOR QUARTER ENDED 31 MARCH 2021 WAS
EUR
317.2M (EUR 238.8M
* EBITDA FOR QUARTER ENDED 31 MARCH 2021 WAS EUR 65.5M (EUR
29.0M), AN INCREASE OF 126 PER CENT AND A MARGIN OF 20.6 PER
CENT (12.2 PER CENT)
* ADJUSTED EBITDAAL FOR QUARTER ENDED 31 MARCH 2021 WAS EUR
54.3M
(EUR 18.1M) AN INCREASE OF 200 PER CENT
* EBITDAAL FOR QUARTER ENDED 31 MARCH 2021 WAS EUR 52.9M
(EUR
16.8M) AN INCREASE OF 215 PER CENT,
* RECENT WAVE OF COVID INFECTIONS HAS SUPPORTED PERFORMANCE
STRONGLY THROUGH MARCH AND FINANCIAL OUTLOOK REMAINS STRONG.
* THERE CONTINUES TO BE A LARGE DEGREE OF UNCERTAINTY ON
PROGRESS
OF INFECTION RATES, COVID-19 VARIANTS
* SOME NEGATIVE IMPACTS FROM COVID PANDEMIC ARE STILL BEING
FELT
AND MAY BECOME MORE APPARENT WITH CURRENT COVID-19 WAVE
Source text for Eikon: ID:nWkrjz1Pr
Further company coverage: MCOVb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))